News | Patient Monitors | August 16, 2018

Lexington Biosciences Concludes Initial HeartSentry Clinical Study

Company prepares for multicenter pivotal clinical study

Lexington Biosciences Concludes Initial HeartSentry Clinical Study

August 16, 2018 — Lexington Biosciences Inc. recently announced the completion of the initial HeartSentry study conducted at San Francisco Bay-area Diablo Clinical Research.

As part of the clinical study protocol, the data acquired from this initial study of the HeartSentry device effectively provides critical guidance for key aspects of the pivotal study itself. With the conclusion of the initial term of work at Diablo Clinical Research, the company moves ahead under the continued leadership of Geoff Tison, M.D. M.P.H, into an advanced stage multicenter trial.

Lexington Biosciences will immediately embark on the implementation of agreements with several trial locations which have been previously contacted as potential study sites. Tison will utilize the initial data to update patient examination protocols as required. Both he and the company will work with each facility to begin enrollment of a significantly larger patient sample from their respective clinical databases.

HeartSentry was designed as a diagnostic device offering a new approach to non-invasive measurement and monitoring of cardiovascular health by assessing the function of a patient’s vascular endothelium, the innermost lining of the cardiovascular system. Lexington Biosciences designed HeartSentry to be accurate, quick and cost-effective, with the intent to position it to become the standard of care for cardiologists, general practitioners, and ultimately for patients as a first-line evaluation of cardiovascular health.

For more information: www.lexingtonbiosciences.com


Related Content

News | Patient Monitors

December 26, 2023 — MindMics, Inc. reported results from a clinical study of revolutionary earbuds that use a new ...

Home December 26, 2023
Home
Feature | Patient Monitors | By Amit Shah, MD, MSCR

I work at Emory University in a multidisciplinary group that is employing medical technologies to improve our ...

Home May 05, 2022
Home
News | Patient Monitors
March 11, 2022 – Bittium will join the 65th Congress of the German Society for Clinical Neurophysiology and Functional ...
Home March 11, 2022
Home
News | Patient Monitors

June 18, 2019 – New study results validate the effectiveness of the Saranas Early Bird Bleed Monitoring System to sense ...

Home June 18, 2019
Home
Technology | Patient Monitors

May 16, 2018 — Itamar Medical Ltd. announced the launch of SleePath, the first integrated e-health sleep apnea care ...

Home May 16, 2018
Home
News | Patient Monitors

March 9, 2018 — Philips recently announced the integration of its IntelliVue Guardian with automated Early Warning ...

Home March 09, 2018
Home
News | Patient Monitors

March 30, 2017 — Acarix AB recently announced the results from a new multi-center trial of its handheld CADScor System ...

Home March 30, 2017
Home
Technology | Patient Monitors

December 8, 2016 — Corsens Medical Ltd. announced that it has received clearance for a Pre-Marketing Notification (510(k ...

Home December 08, 2016
Home
News | Patient Monitors

May 26, 2016 — Corsens Medical Ltd. announced it has successfully completed filing of a Pre-Marketing Notification (510 ...

Home May 26, 2016
Home
Technology | Patient Monitors

February 11, 2016 — Royal Philips announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Expression ...

Home February 11, 2016
Home
Subscribe Now